AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,259,000 | +178.5% | 434,525 | +238.0% | 0.01% | +250.0% |
Q1 2022 | $1,170,000 | +258.9% | 128,574 | +432.1% | 0.00% | -33.3% |
Q1 2020 | $326,000 | -59.5% | 24,165 | +42.7% | 0.00% | -25.0% |
Q1 2019 | $804,000 | +70.3% | 16,940 | +29.5% | 0.00% | -20.0% |
Q4 2018 | $472,000 | +40.5% | 13,082 | +111.0% | 0.01% | -64.3% |
Q1 2018 | $336,000 | – | 6,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |